Patient-reported health-related quality of life (HRQoL) in the randomized FORMULA-509 trial of salvage radiotherapy and 6 months of GnRH agonist with either bicalutamide or abiraterone acetate plus prednisone (AAP) and apalutamide (Apa) after radical prostatectomy (RP) Meeting Abstract
| Authors: | Hoffman, K. E.; Nguyen, P. L.; Rathkopf, D. E.; Zurita, A. J.; Spratt, D. E.; Dess, R. T.; Liauw, S. L.; Szmulewitz, R. Z.; Einstein, D. J.; Bubley, G.; Yu, J. B.; An, Y.; Wong, A. C.; Feng, F. Y.; McKay, R. R.; Rose, B. S.; Shin, K. Y.; Kibel, A. S.; Taplin, M. E.; Kollmeier, M. |
| Abstract Title: | Patient-reported health-related quality of life (HRQoL) in the randomized FORMULA-509 trial of salvage radiotherapy and 6 months of GnRH agonist with either bicalutamide or abiraterone acetate plus prednisone (AAP) and apalutamide (Apa) after radical prostatectomy (RP) |
| Meeting Title: | 2024 ASCO Genitourinary Cancers Symposium |
| Keywords: | 613-302-309; 613-4678-146-349; 261-436; 130-274-2403 |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 42 |
| Issue: | 4 Suppl. |
| Meeting Dates: | 2024 Jan 25-27 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2024-02-01 |
| Language: | English |
| ACCESSION: | WOS:001266676900598 |
| DOI: | 10.1200/JCO.2024.42.4_suppl.260 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 260 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
